当前蛋白身份：P06401
重新检索
差异标签只比较当前检索结果；所有PDB和assembly原始记录仍分别保留。
相关结构差异明细
一行代表一个 PDB 条目中的一个 biological assembly；同一蛋白的多个单体会分别列出。
| PDB 条目 | Assembly / 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与非聚合物 | 实验方法 | 实验环境 | 结构质量 |
|---|---|---|---|---|---|---|---|
| 1A28 HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN 提交 1998-01-19 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：LIGAND BINDING DOMAIN
|
未记录 | STR PROGESTERONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；PROTEIN WAS CRYSTALLIZED FROM 2% PEG 4000, 50 MM PIPES PH 6.5, 350 MM LI2SO4, THEN STABILIZED IN THE SAME BUFFER WITH 21% ETHYLENE GLYCOL
|
分辨率 1.80 Å R-free 0.227 |
| 1A28 HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN 提交 1998-01-19 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
678–933（256 aa）
片段：LIGAND BINDING DOMAIN
|
未记录 | STR PROGESTERONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；PROTEIN WAS CRYSTALLIZED FROM 2% PEG 4000, 50 MM PIPES PH 6.5, 350 MM LI2SO4, THEN STABILIZED IN THE SAME BUFFER WITH 21% ETHYLENE GLYCOL
|
分辨率 1.80 Å R-free 0.227 |
| 1E3K Human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881) 提交 2000-06-19 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
676–933（258 aa）
片段：LIGAND-BINDING DOMAIN
|
未记录 | R18 (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.5；RESERVOIR SOLUTION: 10% ISO-PROPANOL, 100MM SODIUM CITRATE 50MM HEPES PH 7.5. THE DROPS WERE SET UP USING THE HANGING DROP METHOD AND WERE COMPOSED OF A 2:1 RATIO OF PROTEIN AND RESERVOIR SOLUTIONS.
|
分辨率 2.80 Å R-free 0.343 |
| 1E3K Human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881) 提交 2000-06-19 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
676–933（258 aa）
片段：LIGAND-BINDING DOMAIN
|
未记录 | R18 (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.5；RESERVOIR SOLUTION: 10% ISO-PROPANOL, 100MM SODIUM CITRATE 50MM HEPES PH 7.5. THE DROPS WERE SET UP USING THE HANGING DROP METHOD AND WERE COMPOSED OF A 2:1 RATIO OF PROTEIN AND RESERVOIR SOLUTIONS.
|
分辨率 2.80 Å R-free 0.343 |
| 1SQN Progesterone Receptor Ligand Binding Domain with bound Norethindrone 提交 2004-03-19 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
673–933（261 aa）
片段：residues 676-933, ligand binding domain
|
未记录 | NDR (14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；295 K；PEG 1000, Li2SO4. hepes pH 6.5, glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 22K
|
分辨率 1.45 Å R-free 0.216 |
| 1SQN Progesterone Receptor Ligand Binding Domain with bound Norethindrone 提交 2004-03-19 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
673–933（261 aa）
片段：residues 676-933, ligand binding domain
|
未记录 | NDR (14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；295 K；PEG 1000, Li2SO4. hepes pH 6.5, glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 22K
|
分辨率 1.45 Å R-free 0.216 |
| 1SR7 Progesterone Receptor Hormone Binding Domain with Bound Mometasone Furoate 提交 2004-03-22 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
676–933（258 aa）
片段：Ligand binding domain
链 B
676–933（258 aa）
片段：Ligand binding domain
|
未记录 | MOF MOMETASONE FUROATE × 2 SO4 SULFATE ION × 1 GOL GLYCEROL × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；300 K；PEG 1000, Li2SO4, hepes, glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.46 Å R-free 0.211 |
| 1ZUC Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaproget 提交 2005-05-30 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
675–933（259 aa）
链 B
675–933（259 aa）
|
未记录 | T98 5-(4,4-DIMETHYL-2-THIOXO-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-6-YL)-1-METHYL-1H-PYRROLE-2-CARBONITRILE × 2 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；291 K；PEG 3350, MgSO4, PIPES pH 6.5, glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
分辨率 2.00 Å R-free 0.228 |
| 2C7A STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEX 提交 2005-11-19 | Assembly 1 蛋白–DNA 同源多聚体；蛋白 × 2 PDB 声明：tetrameric（4） 与全部聚合物一致 |
链 A
399–476（78 aa）
片段：DNA BINDING DOMAIN, RESIDUES 399-476
链 B
399–476（78 aa）
片段：DNA BINDING DOMAIN, RESIDUES 399-476
|
未记录 | ZN ZINC ION × 4 | X-RAY DIFFRACTION | mmCIF 未提供已读取条件 | 分辨率 2.50 Å R-free 0.246 |
| 2OVH Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT 提交 2007-02-13 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：PR LBD
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；0.1M Tris, 0.4M NaCl, 10% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 2.00 Å R-free 0.222 |
| 2OVH Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT 提交 2007-02-13 | Assembly 2 蛋白异源复合物 异源复合物；蛋白 × 4 PDB 声明：tetrameric（4） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：PR LBD
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；0.1M Tris, 0.4M NaCl, 10% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 2.00 Å R-free 0.222 |
| 2OVM Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoR 提交 2007-02-14 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：Ligand Binding Domain (residues 678-933)
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 8；277 K；0.1M Tris, 0.15M NaCl, 10% glycerol, pH 8.0, spontaneous crystallization, temperature 277K
|
分辨率 2.60 Å R-free 0.244 |
| 2OVM Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoR 提交 2007-02-14 | Assembly 2 蛋白异源复合物 异源复合物；蛋白 × 4 PDB 声明：tetrameric（4） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：Ligand Binding Domain (residues 678-933)
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 8；277 K；0.1M Tris, 0.15M NaCl, 10% glycerol, pH 8.0, spontaneous crystallization, temperature 277K
|
分辨率 2.60 Å R-free 0.244 |
| 2W8Y RU486 bound to the progesterone receptor in a destabilized agonistic conformation 提交 2009-01-20 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：PR LBD, RESIDUES 678-933
|
未记录 | 486 11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；22.5% PEG4000, 0.1M HEPES 6.5, 100 MM LI2SO4
|
分辨率 1.80 Å R-free 0.218 |
| 2W8Y RU486 bound to the progesterone receptor in a destabilized agonistic conformation 提交 2009-01-20 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
678–933（256 aa）
片段：PR LBD, RESIDUES 678-933
|
未记录 | NDR (14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one × 1 EDO 1,2-ETHANEDIOL × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；22.5% PEG4000, 0.1M HEPES 6.5, 100 MM LI2SO4
|
分辨率 1.80 Å R-free 0.218 |
| 3D90 Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel 提交 2008-05-26 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
676–933（258 aa）
片段：Ligand-binding domain, UNP residues 676-933
|
未记录 | NOG 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；8% PEG3350, x300mM MgSO4, 10% Glycerol 10%, 50mM PIPES, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.26 Å R-free 0.279 |
| 3D90 Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel 提交 2008-05-26 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
676–933（258 aa）
片段：Ligand-binding domain, UNP residues 676-933
|
未记录 | NOG 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；8% PEG3350, x300mM MgSO4, 10% Glycerol 10%, 50mM PIPES, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.26 Å R-free 0.279 |
| 3G8O Progesterone Receptor with bound Pyrrolidine 1 提交 2009-02-12 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
673–933（261 aa）
片段：ligand binding domain
链 B
673–933（261 aa）
片段：ligand binding domain
|
未记录 | 30X N~2~-[4-cyano-3-(trifluoromethyl)phenyl]-N,N-dimethyl-N~2~-(2,2,2-trifluoroethyl)-L-alaninamide × 2 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
hanging drop；pH 7；298 K；0.1M Hepes, 0.2M Lithium Sulfate, 15% PEG3350, pH 7.0, hanging drop, temperature 298K
|
分辨率 1.90 Å R-free 0.241 |
| 3HQ5 Progesterone Receptor bound to an Alkylpyrrolidine ligand. 提交 2009-06-05 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：residues 678-933
链 B
678–933（256 aa）
片段：residues 678-933
|
未记录 | SO4 SULFATE ION × 4 GKK 2-chloro-4-{[(3S)-1-methylpyrrolidin-3-yl][2-(trifluoromethyl)benzyl]amino}benzonitrile × 2 GOL GLYCEROL × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 7.5；295.15 K；20 % Peg 3350, 0.2M LiSO4, 0.1M Hepes 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K
|
分辨率 2.10 Å R-free 0.237 |
| 3KBA Progesterone receptor bound to sulfonamide pyrrolidine partial agonist 提交 2009-10-20 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
681–933（253 aa）
片段：Steroid-binding region: UNP residues 681-933
|
未记录 | WOW 2-chloro-4-{(2-methylbenzyl)[(3S)-1-(methylsulfonyl)pyrrolidin-3-yl]amino}benzonitrile × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；20% PEG 3350, 2mM Li2SO4, HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
分辨率 2.00 Å R-free 0.250 |
| 3KBA Progesterone receptor bound to sulfonamide pyrrolidine partial agonist 提交 2009-10-20 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
681–933（253 aa）
片段：Steroid-binding region: UNP residues 681-933
|
未记录 | WOW 2-chloro-4-{(2-methylbenzyl)[(3S)-1-(methylsulfonyl)pyrrolidin-3-yl]amino}benzonitrile × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；20% PEG 3350, 2mM Li2SO4, HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
分辨率 2.00 Å R-free 0.250 |
| 3ZR7 Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES
|
未记录 | OR8 2-CHLORO-N-[[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]METHYL]-1,4-DIMETHYL-1H-PYRAZOLE-4-SULFONAMIDE × 1 GOL GLYCEROL × 5 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.65 Å R-free 0.192 |
| 3ZR7 Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
678–933（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES
|
未记录 | OR8 2-CHLORO-N-[[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]METHYL]-1,4-DIMETHYL-1H-PYRAZOLE-4-SULFONAMIDE × 1 GOL GLYCEROL × 4 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.65 Å R-free 0.192 |
| 3ZRA Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：LIGAND-BINDING DOMAIN, RESIDUES 678-933
|
未记录 | ORB N-{(1R)-1-[4-(2-CHLORO-5-FLUOROPYRIDIN-3-YL)PHENYL]ETHYL}-3,5-DIMETHYLISOXAZOLE-4-SULFONAMIDE × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.
|
分辨率 1.90 Å R-free 0.248 |
| 3ZRA Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
678–933（256 aa）
片段：LIGAND-BINDING DOMAIN, RESIDUES 678-933
|
未记录 | ORB N-{(1R)-1-[4-(2-CHLORO-5-FLUOROPYRIDIN-3-YL)PHENYL]ETHYL}-3,5-DIMETHYLISOXAZOLE-4-SULFONAMIDE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.
|
分辨率 1.90 Å R-free 0.248 |
| 3ZRB Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 678-933
|
未记录 | OR8 2-CHLORO-N-[[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]METHYL]-1,4-DIMETHYL-1H-PYRAZOLE-4-SULFONAMIDE × 1 SO4 SULFATE ION × 1 GOL GLYCEROL × 3 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.80 Å R-free 0.221 |
| 3ZRB Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 提交 2011-06-15 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
678–933（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 678-933
|
未记录 | GOL GLYCEROL × 1 ORC (R)-N-[1-[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]ETHYL]-3,5-DIMETHYLISOXAZOLE-4-SULFONAMIDE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.80 Å R-free 0.221 |
| 4A2J PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 提交 2011-09-27 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
514–769（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 514-769
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.
|
分辨率 2.00 Å R-free 0.251 |
| 4A2J PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 提交 2011-09-27 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
514–769（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 514-769
|
未记录 | AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.
|
分辨率 2.00 Å R-free 0.251 |
| 4APU PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 提交 2012-04-06 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
514–769（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 514-769
|
未记录 | OR8 2-CHLORO-N-[[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]METHYL]-1,4-DIMETHYL-1H-PYRAZOLE-4-SULFONAMIDE × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.90 Å R-free 0.252 |
| 4APU PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 提交 2012-04-06 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
514–769（256 aa）
片段：LIGAND BINDING DOMAIN, RESIDUES 514-769
|
未记录 | A2K (8S,11R,13S,14S,16S,17S)-17-cyclopropylcarbonyl-16-ethenyl-13-methyl-11-(4-pyridin-3-ylphenyl)-2,6,7,8,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-one × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.5；20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL
|
分辨率 1.90 Å R-free 0.252 |
| 4OAR Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT 提交 2014-01-06 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
678–933（256 aa）
片段：Steroid-binding Region
|
未记录 | 2S0 [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopen ta[a]phenanthren-17-yl] acetate × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 8.5；293 K；15% PEG3350, Tris,HCl 50mM, NaCl 400mM, 10% Glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.41 Å R-free 0.234 |